Skip to main content

Table 1 Timeline for IMRA and Madeglucyl development

From: Harnessing biodiversity: the Malagasy Institute of Applied Research (IMRA)

1958

Albert Rakoto-Ratsimamanga establishes IMRA

1965

Albert Rakoto-Ratsimamanga and Suzanne Ratsimamanga begin to work with local healers

1970

IMRA launches its Syzygium cumini (Madeglucyl) project

1984

Initial license for Madeglucyl is registered in Paris

1985

Professors study and experiment with Syzygium cumini seeds at IMRA and the University of Paris.

1993

IMRA is awarded official status as a foundation by government decree

1996

Second license is issued, granting Madeglucyl international recognition

1997

New Drug Application for Madeglucyl is filed and approved in Madagascar

1998

Total harvest of Syzygium cumini seeds reaches 20 tonnes

2007

Production capacity for Madeglucyl reaches 20kg/day (5g/package)